These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19513001)

  • 1. Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer.
    Massodi I; Thomas E; Raucher D
    Molecules; 2009 Jun; 14(6):1999-2015. PubMed ID: 19513001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
    Massodi I; Moktan S; Rawat A; Bidwell GL; Raucher D
    Int J Cancer; 2010 Jan; 126(2):533-44. PubMed ID: 19588502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells.
    Massodi I; Raucher D
    J Drug Target; 2007 Nov; 15(9):611-22. PubMed ID: 17968715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.
    Bidwell GL; Raucher D
    Mol Cancer Ther; 2005 Jul; 4(7):1076-85. PubMed ID: 16020665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
    Bidwell GL; Davis AN; Raucher D
    J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model.
    Bidwell GL; Perkins E; Hughes J; Khan M; James JR; Raucher D
    PLoS One; 2013; 8(1):e55104. PubMed ID: 23372821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
    Dragojevic S; Ryu JS; Hall ME; Raucher D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
    Bidwell GL; Fokt I; Priebe W; Raucher D
    Biochem Pharmacol; 2007 Mar; 73(5):620-31. PubMed ID: 17161827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
    Walker L; Perkins E; Kratz F; Raucher D
    Int J Pharm; 2012 Oct; 436(1-2):825-32. PubMed ID: 22850291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines.
    Thomas E; Dragojevic S; Price A; Raucher D
    Macromol Biosci; 2020 Oct; 20(10):e2000170. PubMed ID: 32734662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer.
    Walker LR; Ryu JS; Perkins E; McNally LR; Raucher D
    Drug Des Devel Ther; 2014; 8():1649-58. PubMed ID: 25336913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.
    Raucher D; Chilkoti A
    Cancer Res; 2001 Oct; 61(19):7163-70. PubMed ID: 11585750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted drug delivery by thermally responsive polymers.
    Chilkoti A; Dreher MR; Meyer DE; Raucher D
    Adv Drug Deliv Rev; 2002 Sep; 54(5):613-30. PubMed ID: 12204595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
    Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
    Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastin-like polypeptides: the influence of its molecular weight on local hyperthermia-induced tumor accumulation.
    Ryu JS; Raucher D
    Eur J Pharm Biopharm; 2014 Oct; 88(2):382-9. PubMed ID: 24866938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.
    Moktan S; Raucher D
    Int J Pept Res Ther; 2012 Sep; 18(3):227-237. PubMed ID: 23105921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
    Ryu JS; Raucher D
    Expert Opin Drug Deliv; 2015 Apr; 12(4):653-67. PubMed ID: 25350837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
    Raucher D; Massodi I; Bidwell GL
    Expert Opin Drug Deliv; 2008 Mar; 5(3):353-69. PubMed ID: 18318656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
    Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
    Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.
    Opačak-Bernardi T; Ryu JS; Raucher D
    J Drug Target; 2017 Jul; 25(6):523-531. PubMed ID: 28140690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.